Notably, AKT acts as an intermediate signalling molecule, influencing glucose uptake and metabolism, regulating insulin sensitivity, and serving as a key mediator in insulin signalling and metabolic control, leading to deterioration of insulin responsiveness and islet cell death, and is closely associated with the development of metabolic syndrome. This evidence concerns the gene AKT1 and metabolic syndrome.